This year’s annual conference of the Obesity Medicine Association (OMA), is set for April 10 through April 12, in San Diego, California. Obesity Medicine 2026 is three days of educational sessions and two days of pre-conference courses for clinicians, educators, and researchers in obesity medicine.

Today, we’re taking a look at some of the sessions currently scheduled for the Obesity Medicine 2026 conference. All times and dates are current as of March 2, 2026. The following rundown does not include the pre-conference courses that take place April 8 and April 9. For a complete look at the conference sessions schedule, visit the official Obesity Medicine 2026 website.

Friday, April 10

The Nutrition Revolution: Understanding Food, Science, and Obesity in a New Era

  • 8:00 AM – 9:00 AM
  • Description: Nutrition science is undergoing a profound transformation shaped by new methodologies, evolving food systems, and the rise of obesity medications that are redefining clinical practice. In this keynote, Dr. Frank Hu will trace the arc of nutrition epidemiology from its early population studies to the more rigorous, technology-enabled approaches emerging today, offering a critical perspective on how the field has evolved and where it is headed.

Managing Male Obesity-Associated Hypogonadism: A Practical Guide

  • 10:30 AM – 11:30 AM
  • Description: By the end of the session, attendees will walk away with a deeper understanding of the interplay between obesity and the hypothalamic-pituitary-gonadal axis, improved diagnostic confidence, and a clear, practical framework for managing male patients presenting with symptoms of low testosterone in the context of obesity.

Navigating the Surgical Pathway in Obesity Care

  • 10:30 AM – 11:30 AM
  • Description: Metabolic/bariatric surgery (MBS) can be an essential component of comprehensive obesity care, and clinicians play a pivotal role in helping patients understand when surgery may be appropriate. This session will review how and when to introduce and discuss surgery early with patients. The session will explore complex case scenarios and discuss the proper preoperative evaluation and optimization of complex patients to assess the potential risks and benefits of MBS. Cases will include the management of obesity medications in pre-, peri-, and postoperative scenarios. Participants will leave with practical strategies for integrating MBS into ongoing obesity treatment and strengthening collaborative care pathways.

Obesity Management in People with Chronic Liver Disease

  • 11:35 AM – 12:35 PM
  • Description: This session will inform attendees beyond the conventional approach to obesity management. It will address the unique needs of patients with chronic liver diseases and the importance of comprehensive and individualized approaches to weight loss. 

Through the Patient’s Eyes: Addressing Body Image in Obesity Care

  • 1:50 PM – 2:35 PM
  • Description: Using real-world clinical cases and lived experience narratives, the session will provide practical tools to support both physical and emotional wellbeing. Teaching will be grounded in cognitive behavioral therapy (CBT) and acceptance and commitment therapy (ACT) frameworks, emphasizing psychological flexibility, values-based goal setting, and identity resilience. 

Expanding Horizons in Adolescent Bariatric Care

  • 2:40 PM – 3:40 PM
  • Description: This session will review current outcomes, safety data, and access issues in adolescent bariatric surgery, highlight the emerging role of endoscopic and alternative metabolic procedures, and discuss best practices for perioperative GLP-1 receptor agonist use.

Surface Symptoms, Deeper Insights

  • 5:00 PM – 5:30 PM
  • Description:  This session explores how integrating dermatologic assessment and treatment into obesity medicine supports comprehensive, patient-centered care and improves long-term outcomes.
Saturday, April 11

Breaking Through Weight Loss Plateaus and Redefining Treatment Success in Obesity Care

  • 9:00 AM – 10:00 AM
  • Description: Rather than focusing primarily on weight loss plateaus themselves, this session reframes the clinical goal to incorporate the meaningful health gains seen with obesity pharmacotherapy, even when the magnitude of weight loss does not align with patient or provider expectations.

Evidence-Based Physical Activity Prescriptions that Work

  • 10:30 AM – 11:30 AM
  • Description: This evidence-driven session equips obesity medicine clinicians with practical tools to confidently assess readiness, ensure safety, and prescribe individualized physical activity using national guidelines. Participants will review the Physical Activity Guidelines for Americans and examine the evidence supporting exercise for adults, older adults, and individuals living with obesity or chronic conditions.

Optimizing Obesity Care for the Geriatric Patient

  • 10:30 AM – 11:30 AM
  • Description: This session provides a practical framework for managing obesity in geriatric patients, emphasizing functional status, sarcopenia risk, and Medicare-specific considerations. We will review the latest body-composition standards, including DXA, BIA, and strength assessments, and demonstrate how to apply these tools through a real-world geriatric case.

Advances in Prediabetes and Diabetes Prevention

  • 11:35 AM – 12:35 PM
  • Description: This session explores practical, case-based approaches to prediabetes management and diabetes prevention, with a special focus on the latest evidence-based guidance for prediabetes and its impact on diabetes prevention efforts. This is a unique session offering an advanced, case-based learning approach with real-world clinically complex patient scenarios that foster practical problem-solving skills directly applicable to daily practice.

Disordered Eating in Pediatric Obesity: Diagnosis to Treatment

  • 1:50 PM – 2:50 PM
  • Description: This session will help providers distinguish between disordered eating and eating disorders, understand how to assess each, and recognize how these patterns may present in patients prescribed obesity medications (OMs). Practical, evidence-informed treatment strategies will be offered for managing disordered eating in patients both on and off OMs. 

GLP1R Agonists: What We Know, What We Don’t, and What Comes Next

  • 1:50 PM – 2:50 PM
  • Description: This session takes a deeper look at the mechanisms behind GLP-1 efficacy—especially their impact on inflammation, neural signaling, and long-term physiology. A central focus will be the modulation of interleukin-6 (IL-6), a cytokine with both pro-inflammatory and homeostatic roles.

AI in Obesity Medicine: Tools to Boost Efficiency and Engagement

  • 3:10 PM – 4:10 PM
  • Description: This session introduces clinicians to the real-world application of generative AI and large language models (LLMs) in obesity care. Rather than focusing on future potential, we will emphasize tools that can be implemented immediately—many of them free or low-code.

Complex Pediatric Obesity Management Using Case-Based Learning

  • 4:15 PM – 5:15 PM
  • Description: Management of difficult clinical conundrums will be addressed through case based scenarios. The goal is to help clinicians handle the most challenging children that present for obesity care. Teaching points will include medical management, combinations of obesity medications, behavioral modification and dietary guidance. The key takeaways will be improved confidence in using OMs in pediatric patients, management of obesity in young children, and sustaining behavioral modifications.
Sunday, April 12

Critical Thinking in Nutrition: Health Outcomes That Matter

  • 8:00 AM – 9:00 AM
  • Description: This session addresses the critical thinking skills needed to solve complex nutrition issues that impact mental, physical and metabolic health outcomes in individuals with obesity. Evidence-based recommendations, clinical reasoning, and nutrition data will be used in case examples to communicate personalized nutrition intervention options. This session is important for obesity medicine clinicians who want to build knowledge and skills in critical reflection, reasoning, and judgment in clinical nutrition decisions for the best health outcomes in patients struggling with obesity.

Lipedema and Obesity: Distinct Diagnoses, Distinct Care

  • 10:15 AM – 11:15 AM
  • Description: This presentation will provide obesity medicine specialists with a practical roadmap for identifying lipedema, distinguishing it from both obesity and lymphedema, and understanding its most common co-morbidities. [The presenters] will outline diagnostic strategies and evidence-based interventions, emphasizing the importance of referrals to lymphatic specialists, anti-inflammatory strategies, and supportive therapies that align with the unique pathophysiology of lipedema.

Mind and Metabolism: Managing Mental Health and Obesity

  • 11:15 AM – 12:00 PM
  • Description: This practical session will provide attendees with an evidence-based framework for managing obesity in patients with coexisting behavioral health conditions. We will review how to safely and effectively use oral OMs particularly when GLP-1 & GIP receptor agonists are contraindicated, unavailable, or unaffordable. Emphasis will be placed on aligning medication choices with coexisting psychiatric symptoms. The session will also address recent concerns about GLP-1 & GIP therapies and anxiety, depression and suicidality and review what the current data shows.

Sign up for alerts and stay informed on the latest clinical guidelines and guideline updates.

Copyright © 2026 Guideline Central, all rights reserved.